Analyst Ratings For Balchem Corporation (NASDAQ:BCPC)
Today, HC Wainwright set its price target on Balchem Corporation (NASDAQ:BCPC) to $101.00 per share.
There are 3 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Balchem Corporation (NASDAQ:BCPC) is Buy with a consensus target price of $109.3333 per share, a potential 34.96% upside.
Some recent analyst ratings include
- 11/6/2018-Balchem Corporation (NASDAQ:BCPC) gets upgraded to Buy by Pivotal Research with a price target of $100.00
- 10/16/2018-Balchem Corporation (NASDAQ:BCPC) gets upgraded to Buy by Sidoti with a price target of $127.00
- 5/7/2018-Balchem Corporation (NASDAQ:BCPC) gets downgraded to Hold by Vertical Group
- On 11/13/2018 Daniel E Knutson, Director, bought 650 with an average share price of $89.11 per share and the total transaction amounting to $57,921.50.
- On 6/15/2017 Edward Mcmillan, Director, sold 2,557 with an average share price of $81.09 per share and the total transaction amounting to $207,347.13.
- On 3/13/2017 William A Backus, CFO, sold 48,500 with an average share price of $83.60 per share and the total transaction amounting to $4,054,600.00.
- On 3/3/2017 William A Backus, CFO, sold 14,000 with an average share price of $86.88 per share and the total transaction amounting to $1,216,320.00.
- On 1/4/2017 Edward Mcmillan, Director, sold 1,550 with an average share price of $85.00 per share and the total transaction amounting to $131,750.00.
- On 12/8/2016 Dino A. Rossi, Director, sold 16,762 with an average share price of $84.68 per share and the total transaction amounting to $1,419,406.16.
- On 11/16/2016 Dino A. Rossi, Director, sold 16,400 with an average share price of $77.85 per share and the total transaction amounting to $1,276,740.00.
About Balchem Corporation (NASDAQ:BCPC)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include creamer and chocolate systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.
Recent Trading Activity for Balchem Corporation (NASDAQ:BCPC)
Shares of Balchem Corporation closed the previous trading session at 81,01 −0,76 0,93 % with 110100 shares trading hands.
